• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过MHC II类抗原表达消除致瘤性需要II类分子的胞质结构域。

Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule.

作者信息

Ostrand-Rosenberg S, Roby C A, Clements V K

机构信息

University of Maryland Baltimore County, Department of Biological Sciences 21228.

出版信息

J Immunol. 1991 Oct 1;147(7):2419-22.

PMID:1918972
Abstract

Transfection of syngeneic MHC class II genes into the lethal mouse SaI tumor abrogates the malignancy of the tumor in the autologous host, and protects the host against subsequent challenges with the wild type class II- tumor. We have hypothesized that the transfectants induce protective immunity by functioning as APC for tumor peptides, and stimulating tumor-specific Th cells. Recent in vitro studies suggest that Ag presentation by class II-restricted APC requires the cytoplasmic domain of the class II molecule, and may involve intracellular signaling via the cytoplasmic domain. To determine if the class II cytoplasmic domain is required for enhanced tumor-specific immunity, SaI mouse sarcoma cells were transfected with syngeneic Aak and Abk genes with truncated cytoplasmic domains. These transfectants are as malignant as wild type class II- SaI cells in autologous A/J mice. Stimulation of tumor-specific immunity by class II+ tumor cells is therefore dependent on the class II cytoplasmic region, and may involve intracellular signaling events.

摘要

将同基因的MHC II类基因转染到致死性小鼠SaI肿瘤中,可消除该肿瘤在自体宿主中的恶性程度,并保护宿主免受野生型II类肿瘤随后的攻击。我们推测,转染子通过作为肿瘤肽的抗原呈递细胞并刺激肿瘤特异性Th细胞来诱导保护性免疫。最近的体外研究表明,II类限制性抗原呈递细胞的抗原呈递需要II类分子的胞质结构域,并且可能涉及通过胞质结构域的细胞内信号传导。为了确定增强肿瘤特异性免疫是否需要II类胞质结构域,用具有截短胞质结构域的同基因Aak和Abk基因转染SaI小鼠肉瘤细胞。这些转染子在自体A/J小鼠中与野生型II类SaI细胞一样具有恶性。因此,II类阳性肿瘤细胞对肿瘤特异性免疫的刺激取决于II类胞质区域,并且可能涉及细胞内信号传导事件。

相似文献

1
Abrogation of tumorigenicity by MHC class II antigen expression requires the cytoplasmic domain of the class II molecule.通过MHC II类抗原表达消除致瘤性需要II类分子的胞质结构域。
J Immunol. 1991 Oct 1;147(7):2419-22.
2
Invariant chain alters the malignant phenotype of MHC class II+ tumor cells.
J Immunol. 1992 Oct 1;149(7):2391-6.
3
Rejection of mouse sarcoma cells after transfection of MHC class II genes.转染MHC II类基因后小鼠肉瘤细胞的排斥反应。
J Immunol. 1990 May 15;144(10):4068-71.
4
Rejection of MHC class II-transfected tumor cells requires induction of tumor-encoded B7-1 and/or B7-2 costimulatory molecules.对MHC II类转染肿瘤细胞的排斥反应需要诱导肿瘤编码的B7-1和/或B7-2共刺激分子。
J Immunol. 1996 May 15;156(10):3821-7.
5
Single amino acid mutations in the murine MHC class II A beta cytoplasmic domain abrogate antigen presentation.小鼠MHC II类Aβ胞质结构域中的单氨基酸突变可消除抗原呈递。
J Immunol. 1997 Dec 15;159(12):5914-20.
6
Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.同基因宿主中K1735鼠黑色素瘤的排斥反应需要MHC I类抗原以及II类抗原或白细胞介素-2的表达。
J Immunol. 1993 Jul 1;151(1):244-55.
7
Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes.通过用同基因MHC-II类基因或异基因MHC-I类基因转染肿瘤细胞,可以增强肿瘤特异性免疫。
Int J Cancer Suppl. 1991;6:61-8. doi: 10.1002/ijc.2910470714.
8
Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
J Immunol. 1995 Jan 15;154(2):738-43.
9
Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.β淀粉样蛋白分子胞质结构域对于II类分子介导的B细胞信号传导的长度及序列要求。
J Immunol. 1993 Nov 15;151(10):5282-9.
10
Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.来自被隔离在抗原呈递细胞细胞质或内质网中的内源性抗原的鸡卵溶菌酶决定簇的II类限制性呈递。
J Immunol. 1993 May 1;150(9):3690-7.

引用本文的文献

1
Metastatic melanoma cells evade immune detection by silencing STAT1.转移性黑色素瘤细胞通过使信号转导和转录激活因子1(STAT1)沉默来逃避免疫检测。
Int J Mol Sci. 2015 Feb 17;16(2):4343-61. doi: 10.3390/ijms16024343.
2
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?CD4(+) T细胞如何检测和清除缺乏或表达II类主要组织相容性复合体分子的肿瘤细胞?
Front Immunol. 2014 Apr 15;5:174. doi: 10.3389/fimmu.2014.00174. eCollection 2014.
3
Diversity in MHC class II antigen presentation.MHC II类抗原呈递的多样性。
Immunology. 2002 Mar;105(3):252-62. doi: 10.1046/j.0019-2805.2001.01358.x.
4
The central role of CD4(+) T cells in the antitumor immune response.CD4(+) T细胞在抗肿瘤免疫反应中的核心作用。
J Exp Med. 1998 Dec 21;188(12):2357-68. doi: 10.1084/jem.188.12.2357.
5
Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.主要组织相容性复合体II类转染的肿瘤细胞呈递内源性抗原,是肿瘤特异性免疫的有效诱导剂。
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6886-91. doi: 10.1073/pnas.94.13.6886.
6
Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.II类β链胞质结构域的截短会影响II类/恒定链衍生肽复合物的水平。
Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):241-4. doi: 10.1073/pnas.93.1.241.
7
Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.人类CD4 + T细胞特异性识别由酪氨酸酶基因编码的一种共享的黑色素瘤相关抗原。
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9461-5. doi: 10.1073/pnas.91.20.9461.
8
Major histocompatibility complex class II+B7-1+ tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice.主要组织相容性复合体II类+B7-1+肿瘤细胞是用于刺激荷瘤小鼠肿瘤排斥反应的高效疫苗。
J Exp Med. 1995 Feb 1;181(2):619-29. doi: 10.1084/jem.181.2.619.
9
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.B7的组成型表达可恢复表达截短的主要组织相容性复合体II类分子的肿瘤细胞的免疫原性。
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5687-90. doi: 10.1073/pnas.90.12.5687.